13th International Bordetella Symposium

第13届国际博德特氏菌研讨会

• 批准号: 10506485
• 负责人: Fredrick Heath Damron
• 金额: $ 1.5万
• 依托单位: WEST VIRGINIA UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-04-01 至 2023-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10506485
• 关键词: 13th; International; Bordetella; Symposium

Project Summary/Abstract: Whooping cough, also known as Pertussis, is a respiratory disease caused by the bacterial pathogen Bordetella pertussis. Pertussis is one of the world’s leading causes of vaccine-preventable deaths and is currently the only vaccine-preventable bacterial disease that is increasing in incidence. Despite high vaccine coverage, whooping cough (pertussis) has re-emerged as a major public health concern in the US and the world. Recently, it was estimated that there were 24 million pertussis cases and 160,700 deaths in children younger than 5 years around the world per year. In addition to being added to the NIH emerging infectious pathogens list in 2015, the CDC recently listed Bordetella pertussis on its new Watch List in the 2019 Antibiotic Resistance Threats Report because of the unknown future burden of this highly contagious bacterium. Since the 1960’s, the Bordetella research community has organized an International Bordetella Symposium, the 12th symposium was hosted at Brussels University by Dr. Camille Locht, in April of 2019. In an effort to increase dissemination of new data and exchange of ideas, Dr. Ciaran Skerry hosted the 1st ever Bordetella Research Day at the University of Maryland in April, 2018. The Bordetella Research Day was meant to be a U.S-based conference for Bordetella researchers to meet during the off years of the International Bordetella Symposiums. Due to the COVID-19 pandemic, both the 2020 Bordetella Research Day, and the 2021 International Bordetella Symposium were postponed. To continue dissemination of important research, the International Bordetella Society hosted a zoom-based conference in August 2020 which garnered attendance from academia, the CDC, FDA, NIH, and many pharmaceutical companies. The major success of this online event resulted in the Bordetella Society creating a monthly Lab Meeting Series, where different groups around the world can showcase their latest research. In order to further support the development of the next generation of scientists, this R13 application is requesting funds from the FDA Center for Biologics Evaluations and Research (CBER) to support travel associated costs for junior scientists (pre- and post-doctoral) to attend and present innovative research at the 13th International Bordetella Symposium hosted at the University of British Columbia in Vancouver, Canada (June 2022).

项目摘要/摘要： 百日咳，又称百日咳，是一种由细菌病原体波氏杆菌引起的呼吸道疾病。 百日咳。百日咳是世界上可疫苗预防的死亡的主要原因之一，目前是唯一 发病率正在增加的疫苗可预防的细菌性疾病。尽管疫苗覆盖率很高，但欢呼 咳嗽(百日咳)再次成为美国和世界的一个主要公共卫生问题。最近，它是 估计有2400万例百日咳病例和160700例5岁以下儿童死亡 每年一次的世界。除了在2015年被列入美国国立卫生研究院新兴传染病病原体名单外，美国疾病控制与预防中心 最近在2019年抗生素耐药性威胁报告中将百日咳杆菌列入其新的观察名单 因为这种高传染性细菌未来的负担是未知的。自20世纪60年代以来，S，波尔德泰拉 研究界组织了一次国际波尔德特拉研讨会，第12届研讨会在 布鲁塞尔大学卡米尔·洛希特博士于2019年4月发表。为了努力增加新数据的传播和 思想交流，Ciaran Skerry博士在马里兰大学主持了有史以来第一个波尔德泰拉研究日 2018年4月。波尔德泰拉研究日是波尔德泰拉研究人员在美国举行的一次会议 在国际波尔德泰拉研讨会的淡季举行会议。由于新冠肺炎大流行，两者 2020年波尔德泰拉研究日和2021年波尔德泰拉国际研讨会被推迟。至 继续传播重要研究成果，国际波尔德特拉学会主办了一次基于ZOOM的 2020年8月举行的一次会议，学术界、疾病控制与预防中心、FDA、NIH和许多 制药公司。这一在线活动的重大成功导致波尔德泰拉协会创建了一个 每月实验室会议系列，世界各地的不同团体可以在这里展示他们的最新研究。在……里面 为了进一步支持下一代科学家的发展，这款R13应用程序请求 来自FDA生物制品评估和研究中心(CBER)的资金，以支持与旅行相关的费用 初级科学家(博士后和博士后)参加第13届国际会议并发表创新研究报告 波尔德泰拉研讨会在加拿大温哥华不列颠哥伦比亚大学主办(2022年6月)。